EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.4.21.73 | additional information | increased plasminogen activator activity in the lung by administering exogenous uPA or by using mice genetically deficient in the uPA inhibitor plasminogen activator inhibitor-1, PAI-1 | Mus musculus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.21.73 | plasminogen activator inhibitor-1 | an endogenous inhibitor protein, i.e. PAI-1 | Mus musculus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.21.73 | additional information | Mus musculus | inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model, overview. The uPA/plasmin system participates in pericellular proteolysis and is capable of directly degrading matrix components, activating latent proteinases, and activating growth factors | ? | - |
? | |
3.4.21.73 | additional information | Mus musculus C57/BL6J | inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model, overview. The uPA/plasmin system participates in pericellular proteolysis and is capable of directly degrading matrix components, activating latent proteinases, and activating growth factors | ? | - |
? | |
3.4.21.73 | plasminogen + H2O | Mus musculus | - |
plasmin + ? | - |
? | |
3.4.21.73 | plasminogen + H2O | Mus musculus C57/BL6J | - |
plasmin + ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.21.73 | Mus musculus | - |
C57BL/6J mice | - |
3.4.21.73 | Mus musculus C57/BL6J | - |
C57BL/6J mice | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.21.73 | epithelial cell | - |
Mus musculus | - |
3.4.21.73 | fibroblast | - |
Mus musculus | - |
3.4.21.73 | lung | asthma model mice | Mus musculus | - |
3.4.21.73 | additional information | uPA expression analysis in lung, overview | Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.21.73 | additional information | inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model, overview. The uPA/plasmin system participates in pericellular proteolysis and is capable of directly degrading matrix components, activating latent proteinases, and activating growth factors | Mus musculus | ? | - |
? | |
3.4.21.73 | additional information | inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model, overview. The uPA/plasmin system participates in pericellular proteolysis and is capable of directly degrading matrix components, activating latent proteinases, and activating growth factors | Mus musculus C57/BL6J | ? | - |
? | |
3.4.21.73 | plasminogen + H2O | - |
Mus musculus | plasmin + ? | - |
? | |
3.4.21.73 | plasminogen + H2O | - |
Mus musculus C57/BL6J | plasmin + ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.21.73 | uPA | - |
Mus musculus |
3.4.21.73 | Urokinase-type plasminogen activator | - |
Mus musculus |